Navigation Links
Innovative Drugs to Transform European Alzheimer's Disease Medication Market by 2015, Says Frost & Sullivan
Date:11/14/2012

LONDON, Nov. 14, 2012 /PRNewswire/ -- The patent expiry of all four existing EMEA approved drugs for Alzheimer's disease (AD) by 2015 is likely to cause a steep decline in the growth of the European AD medication market. However, the approval of next generation therapies that can delay disease progression and restore cognitive functions are expected to revive opportunities in the market from 2015 to 2018.

New analysis from Frost & Sullivan (http://www.healthcare.frost.com), European Alzheimer's Disease Medication Market, estimates the market to earn $1.80 billion in 2012 and reach $4.78 billion in 2019, growing at a compound annual growth rate (CAGR) of 15.1% from 2012-2019.

"Increasing R&D activity and a strong pipeline of disease modifying drugs bode well for market expansion," notes Frost & Sullivan Senior Research Analyst Aiswariya Chidambaram. "Considerable unexplored opportunities and the commercial goldmine that is the AD medication market have motivated several pharmaceutical and biotechnology companies to invest in R&D, particularly targeting the moderate-to-severe patient group."

Existing drug classes for AD offer poor therapeutic efficacy. The core focus of new R&D approaches has therefore centered on novel disease modifying drugs.

"These drugs are expected to offer potential benefits over conventional therapeutic options as they are safer, more effective and aim to prevent or slow down disease progression rather than provide just symptomatic relief," adds Chidambaram. "Therefore, these new drugs are expected to command premium prices and fuel market growth."

A key challenge at present is the looming patent expiry of key blockbuster drugs including Aricept, Exelon Patch and Ebixa. Their going off-patent is set to unleash a flood of cheaper generic equivalents that will result in lowered market revenues.

The accurate diagnosis of A
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Coloplast Launches the Innovative Altis Single Incision Sling System
2. DebMed Selected By Three Leading Healthcare Group Purchasing Organizations To Demonstrate Innovative Patient Safety Solution
3. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
4. Tranzbyte Corporation Acquires the Exclusive Right to Market Low-Cost, Innovative MRI machines in North and South America
5. Ixonos Provides NHS Choices With Innovative Health Apps
6. Pomona Valley Hospital is First in the Region to Use Innovative Technology for Neonates
7. New Jersey Health Foundation Initiates Program To Spur Innovative Research
8. Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
9. CVS Caremark Charitable Trust Partners with National Association of Community Health Centers to Create Innovative Grant Program Focused on Managing Chronic Disease
10. Dr. Milton Owens, Well Known Bariatric Surgeon, Introduces Innovative "Inverted Corner Gastric Sleeve technique," An advanced technique that makes weight loss surgery even safer
11. Synapse Develops Technology for Innovative Asthma Management Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/rq47bp/global_pressure ... Pressure Relief Devices Market 2015-2019" report to their ... to grow at a CAGR of 4.41% over the ... Market 2015-2019, has been prepared based on an in-depth ... covers the Americas, and the APAC and EMEA; it ...
(Date:7/27/2015)... , July 27, 2015  QT Vascular Ltd., ... a global company engaged in the design, assembly and ... treatment of vascular disease, has entered into an agreement ... to US$13.14 million convertible bond investment. This funding will ... its growth to the next milestone. ...
(Date:7/27/2015)... July 27, 2015  Array BioPharma Inc. ... for the fourth quarter and full year ... call to discuss those results on Monday, ... Officer will lead the call. ... 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, including Replay ...
Breaking Medicine Technology:Global Pressure Relief Devices Market 2015-2019 with ArjoHuntleigh, Hill-Rom, Paramount Bed Holdings & Stryker Dominating 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 2QT Vascular Obtains Funding To Boost Growth Through Issuance of up to US$13.14 Million Convertible Bonds 3
... Transplant Patients Represents First, Pivotal Study on a New Antiviral CMV Therapy in Stem Cell ... Over a Decade ... ... 29 ViroPharma Incorporated,(Nasdaq: VPHM ) today announced that it completed enrollment in its pivotal,Phase ...
... be Presented at ASCO Shows Survival Benefit in Complete ... Partial Responders Compared with Chemotherapy Alone, BERKELEY ... GNTA) announced the results of long-term,followup from a Phase ... sodium) Injection, in patients with chronic,lymphocytic leukemia (CLL). With ...
Cached Medicine Technology:ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients 2ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients 3ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients 4ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients 5ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients 6Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4
(Date:7/27/2015)... Church, VA (PRWEB) , ... July 27, 2015 ... ... and Compliance From Step One, **FDAnews Webinar**, Aug. 13, 2015 — 1:30 p.m. ... procedures are one of the first things FDA investigators will look at during ...
(Date:7/27/2015)... ... July 27, 2015 , ... Looking to brush up on all ... Blue Shield of New Jersey has enhanced its Dental webpage with new materials, including ... teeth. , “Horizon is committed to offering our 3.8 million members tools and ...
(Date:7/27/2015)... ... July 27, 2015 , ... Send Word ... and mobile collaboration, announced today the latest software release for its ... other feature enhancements. , This software release gives the widely used online application ...
(Date:7/27/2015)... ... July 27, 2015 , ... In an ongoing program ... to its options. Already an industry leader because of its use of iPad ... the latest successful trends in helping people to overcome addiction and live healthy, ...
(Date:7/27/2015)... NJ (PRWEB) , ... July 27, 2015 , ... Gary ... Jersey. Dr. Breslow is Founder and Medical Director of The Breslow Center in ... the face, breast, and body in Northern New Jersey. The Breslow Center also ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 2Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 3Health News:FDAnews Announces — Writing Effective Standard Operating Procedures: Ensure Quality and Compliance From Step One Webinar, Aug. 13, 2015 4Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2Health News:Send Word Now Announces Release of New User Interface for its Award-Winning Mass Notification Service 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3Health News:NJ Top Doc, Dr. Gary Breslow, has launched Zwivel; a New Online Cosmetic Consultation Service for Doctors and Patients 2
... rank facilities don,t take all measurements into account , TUESDAY, ... onto the U.S. News & World Report list ... in some measurements regarding heart failure, researchers say. , "If ... the areas of heart failure mortality and readmission, you should ...
... be done up to 21 hours later with milder heart ... Many people who arrive at hospital emergency rooms with chest ... angioplasty, even if an electrocardiogram (EKG) shows evidence of a ... no significant difference in key measures of heart damage and ...
... 1 Zimmer Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced ... of September: , , , Thomas ... 11:30 a.m. Eastern Time; , Morgan Stanley Healthcare Unplugged ... Eastern Time; and , UBS Global Life Sciences Conference ...
... , , , ... Hospital has earned the U.S. Environmental Protection Agency,s (EPA,s) prestigious ... environmental protection. St. Anthony,s is the first hospital in Florida ... achieve this recognition. Buildings that receive the EPA,s ENERGY STAR ...
... CHSI Solutions Hotline Provides NRSIG Members Immediate Medical Assessment -- ... September 1, 2009, employees of Nevada Restaurant Self-Insured Group members injured ... assessment from a medical professional when they call the CHSI Solutions ... Hotline will be available to NRSIG members and their employees all ...
... , , , ... an operating subsidiary of WellPoint, Inc. (NYSE: WLP ) and one ... on diagnostic imaging that appear in the August 27, 2009 issue of the ... article "Exposure to Low-Dose Ionizing Radiation from Medical Procedures" reviews the ...
Cached Medicine News:Health News:Government Best Source for U.S. Hospital Data, Study Finds 2Health News:Sometimes Angioplasty Can Wait 2Health News:St. Anthony's Hospital Is First to Earn EPA'S ENERGY STAR(R) Symbol for Superior Energy Efficiency 2Health News:St. Anthony's Hospital Is First to Earn EPA'S ENERGY STAR(R) Symbol for Superior Energy Efficiency 3Health News:Nevada Restaurant Self-Insured Group Launches 24-Hour Injury Hotline on September 1 to Ensure Employee Safety 2Health News:American Imaging Management Reacts to New England Journal of Medicine Articles on Diagnostic Imaging 2
Bone Curette, 160 mm...
Bone Currettes...
London Endocervical Curette is a stainless-steel curette for obtaining endocervical samples with minimal effort....
...
Medicine Products: